Vertical polarization beam splitter using a hybrid long-range surface plasmon polariton waveguide

2014 ◽  
Vol 16 (2) ◽  
pp. 025501 ◽  
Author(s):  
Jin Tae Kim ◽  
Suntak Park
2003 ◽  
Vol 797 ◽  
Author(s):  
Victor Coello ◽  
Thomas Søndergaard ◽  
Sergey I. Bozhevolnyi

ABSTRACTWe model the operation of a micro-optical interferometer for surface plasmon polaritons (SPPs) that comprises an SPP beam-splitter formed by equivalent scatterers lined up and equally spaced. The numerical calculations are carried out by using a vector dipolar model for multiple SPP scattering. The SPP beam-splitter is simulated for different angles of the incident SPP beam, radii of the particles, and inter-particle distances in order to find a suitable configuration for realization of a 3dB SPP beam-splitter. The results obtained are in good agreement with experimental data available in the literature. The feasibility of fabricating an interferometer is thereby corroborated and the calculated intensity maps are found rather similar to those experimentally reported.


2009 ◽  
Vol 95 (9) ◽  
pp. 091104 ◽  
Author(s):  
Fang Liu ◽  
Ruiyuan Wan ◽  
Yunxiang Li ◽  
Yidong Huang ◽  
Yoshikatsu Miura ◽  
...  

2016 ◽  
Vol 28 (6) ◽  
pp. 633-636 ◽  
Author(s):  
Lanting Ji ◽  
Tong Liu ◽  
Guobing He ◽  
Xiaoqiang Sun ◽  
Xibin Wang ◽  
...  

Sensors ◽  
2019 ◽  
Vol 19 (3) ◽  
pp. 631 ◽  
Author(s):  
Oleksiy Krupin ◽  
Pierre Berini

Straight long-range surface plasmon-polariton (LRSPP) waveguides as biosensors for label-free detection are discussed. The sensors consist of 5-μm-wide 35-nm-thick gold stripes embedded in a low-index optical-grade fluoropolymer (CYTOPTM) with fluidic channels etched to the Au surface of the stripes. This work demonstrates the application of the LRSPP biosensors for the detection of human cardiac troponin I (cTnI) protein. cTnI is a biological marker for acute myocardial infarction (AMI), often referred to as a heart attack, which can be diagnosed by elevated levels of cTnI in patient blood. Direct and sandwich assays were developed and demonstrated over the concentration range from 1 to 1000 ng/mL, yielding detection limits of 430 pg/mL for the direct assay and 28 pg/mL for the sandwich assay (1 standard deviation), the latter being physiologically relevant to the early detection or onset of AMI. In addition, a novel approach for data analysis is proposed, where the analyte response is normalized to the response of the antibody layer.


Sign in / Sign up

Export Citation Format

Share Document